Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study is a research paper published in medRxiv (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 2R01LM006910-14
Discovering and Applying Knowledge in Clinical Databases
National Institutes of Health
Grant: 1R01HS022882-01
Understanding hospital readmission rates: patient, hospital and community effects
National Institutes of Health
Grant: 5K23HL153775-05
Evaluating and Improving Utilization of Evidence-Based Medical Therapy in Patients with Heart Failure using Automated Tools in the Electronic Health Record
National Institutes of Health
Grant: 5R01HG006139-06
Genomics, GPUs, and Next Generation Computational Statistics
National Institutes of Health
Grant: 5U01FD005938-04
Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI)
National Institutes of Health
Grant: 5R01HL144644-02
Leveraging Physician Networks to Improve Care and Outcomes for Low-Income Populations
Wellcome Trust
Grant: 214588
Approaches for Creating Clinical Evidence of treatment effects in routine Populations excluded from Trials (ACCEPT)
National Institutes of Health
Grant: 1R01HL169954-01
Real-world Evidence to Inform Decisions for Hypertension Treatment Escalation
National Institutes of Health
Grant: 5R01HS025164-04
Medical reversals: De-implementing ineffective and unsafe treatments
National Institutes of Health
Grant: 5T32HL155000-03
Training in Implementation Science Research and Methods
NLM NIH HHS
Grant: T15 LM007079
NHLBI NIH HHS
Grant: R01 HL144644
NLM NIH HHS
Grant: R01 LM006910
NHGRI NIH HHS
Grant: R01 HG006139
AHRQ HHS
Grant: R01 HS022882
NHLBI NIH HHS
Grant: R01 HL169954
FDA HHS
Grant: U01 FD005938
NHLBI NIH HHS
Grant: T32 HL155000
AHRQ HHS
Grant: R01 HS025164
NHLBI NIH HHS
Grant: K23 HL153775
Wellcome Trust
Fields of Study
Keywords
Sustainable Development Goals